期刊文献+

STAT3磷酸化调控乳腺癌髓系来源抑制细胞介导T细胞免疫抑制的机制研究 被引量:3

Activation of STAT3 promoting immunosuppressive effect on T cells in MDSCs of breast cancer
下载PDF
导出
摘要 目的:检测STAT3在乳腺癌MDSCs中的磷酸化状态及其对MDSCs免疫抑制活性的影响。方法:收集脐血单个核细胞,免疫磁珠的方法分选其中CD33+细胞,体外与乳腺癌细胞系MDA-MB-231共孵育诱导MDSC生成。Western blot方法分别检测IDO和STATs的表达与磷酸化情况。MDSCs与健康供者外周血T淋巴细胞共孵育,分别加入1-MT和JSI-124来抑制IDO功能和STAT3磷酸化,利用MTT实验和ELISA检测各组T细胞的增殖和细胞因子分泌。结果:Western blot检测发现体外诱导的MDSCs中IDO表达明显增加,同时伴STAT3磷酸化水平升高。加入JSI-124后pSTAT3和IDO表达明显降低。MTT实验中MDSCs明显抑制T细胞增殖,加用IDO特异性抑制剂1-MT或STAT3抑制剂JSI-124后T细胞增殖抑制明显改善(P<0.05),且1-MT组和JSI-124组之间差异无统计学意义。ELISA结果显示MDSCs显著抑制T细胞分泌IFN-γ,促进TGF-β、IL-10释放(P<0.05)。而加用1-MT或JSI-124后,IFN-γ分泌水平升高,而TGF-β、IL-10分泌水平降低(P<0.05),而1-MT组和JSI-124组之间差异无统计学意义。结论:MDSCs中磷酸化STAT3水平升高导致IDO过表达;STAT3的特异性抑制剂JSI-124可以逆转MDSCs对T细胞增殖和Th1类因子分泌的抑制作用。 Objective:To explore the status of STAT3 phosphorylation in myeloid-derived suppressor cells (MDSCs) of breast cancer and its function in the immunosuppressive effect of MDSCs on proliferation and cytokine secretion of T cells. Methods:CCD33+cells were isolated from healthy umbilical cord, blood-derived, peripheral blood mononuclear cells and were co-cultured with breast cancer cell line MDA-MB-231 in vitro using Transwell plates to induce MDSCs. The untreated CD33+cells were used as con-trols. Idoxuridine (IDO) suppressor expression and STAT3 phosphorylation were examined using Western blot assay. The proliferation and cytokine secretion of T cells, which were co-cultured with MDSCs, were determined by methyl thiazol tetrazolium assay and en-zyme-linked immunosorbent assay. 1-MT and JSI-124 were used to investigate the function of IDO and pSTAT3 in MDSC-mediated T cell immunosuppression. Results:The protein levels of IDO and pSTAT3 in MDSCs were significantly upregulated. MDSCs obviously suppressed T-cell proliferation, which was reversed by 1-MT or JSI-124 (P〈0.05). MDSCs could promote TGF-βand IL-10 secretions, but could also remarkably inhibit IFN-γsecretion (P〈0.05). After incubation with 1-MT or JSI-124, the increase in TGF-βand IL-10, as well as the decrease in IFN-γ, was significantly reversed. Conclusion:The upregulated pSTAT3 induced the IDO increase in MDSCs. JSI-124 can block MDSC-mediated immunosuppressive effect on T cells in breast cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第17期1016-1019,共4页 Chinese Journal of Clinical Oncology
基金 国家重点基础研究发展计划(编号:2012CB9333004) 国家自然科学基金项目(编号:81072159) 天津市高等学校科技发展基金计划项目(编号:20090133)资助~~
关键词 髓系来源抑制细胞 STAT3 T细胞 乳腺癌 MDSCs, STAT3, T cell, breast cancer
  • 相关文献

参考文献15

  • 1Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated reg- ulation of myeloid cells by mmours[J]. Nat Rev Immunol, 2012, 12 (4) : 253--268. 被引量:1
  • 2SchmieiauJ, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients[J]. Cancer Res, 2001, 61 (12) :4756-4760. 被引量:1
  • 3Hoechst B, Gamrekelashvili J, Manns MP, et al. Plasticity of hu- man Th17 cells and iTregs is orchestrated by different subsets of myeloid cells[J]. Blood, 2011, 117(24):6532-6541. 被引量:1
  • 4Sakuishi K, Jayaraman P, Behar SM, et al. Emerging Tim-3 functions in antimicrobial and tumor immunity[J]. Trends Immunol, 2011, 32(8): 345-349. 被引量:1
  • 5沈春,于津浦,李慧,曹水,刘俊田,孙敬岩,辛宁,安秀梅,于文文,任秀宝.乳腺癌患者髓系来源抑制性细胞的鉴定与免疫作用研究[J].中国肿瘤临床,2009,36(17):1010-1015. 被引量:7
  • 6杜伟娇,于津浦,李慧,李润美,于文文,安秀梅,张乃宁,曹水,任秀宝.肿瘤诱导的髓系来源抑制细胞中IDO表达相关机制研究[J].中国肿瘤临床,2011,38(7):372-376. 被引量:5
  • 7Marigo I, Bosio E, Solito S, et al. Tumor-induced tolerance and im- mune suppression depend on the C/EBPbeta transcription factor[J]. Immunity, 2010, 32 (6) :790-802. 被引量:1
  • 8Ichikawa M, Williams R, Wang L, et al. S100AS/A9 activate key genes and pathways in colon tumor progression[J]. Mol Cancer Res, 2011, 9(2):133-148. 被引量:1
  • 9Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid--derived suppressor cell differentiation and function[J]. Trends Immunol, 2011, 32 (1) : 19-25. 被引量:1
  • 10杨宝宏,于津浦,李慧,任宝柱,刘俊田,安秀梅,刘婷,任秀宝.乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探[J].中国肿瘤临床,2012,29(9):506-509. 被引量:6

二级参考文献24

  • 1Movahedi K, Guilliams M, Van den BosscheJ, et al. Identification of discrete rumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell - suppressive activity[J]. Blood, 2008, 111(8): 4233-4244. 被引量:1
  • 2YounJI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice[J]. J Immunol, 2008, 181 (8) : 5791-5802. 被引量:1
  • 3Dolcetti L, Marigo I, Mantelli B, et al. Myeloid- derived suppressor cell role in tumor-related inflammation[J]. Cancer Lett, 2008, 267(2): 216-225. 被引量:1
  • 4KoJS, Zea AH, Rini BI, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients[J]. Clin Cancer Res, 2009,15(6): 2148-2157. 被引量:1
  • 5Filipazzi P, Valenti R, Huber V, et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antimmor vaccine[J]. J Clin Oncol, 2007, 25(18): 2546-2553. 被引量:1
  • 6Diaz-Montero CM, Salem ML, Nishimura MI, et al. Increased circulating myeloid-derived suppressor ceils correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy[J]. Cancer Immunol Immunother, 2009, 58(1): 49-59. 被引量:1
  • 7Kusmartsev S, Su Z, Heiser A, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma[J]. Clin Cancer Res ,2008, 14(24): 8270-8278. 被引量:1
  • 8Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment,phenotype,properties,and mechanisms of immune suppression[J]. Semin Cancer Biol, 2006, 16(1): 53-65. 被引量:1
  • 9Kusmartsev S, Nagaraj S, Gabrilovich DI. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells[J].J Immunol, 2005, 175(7): 4583-4592. 被引量:1
  • 10Capuano G, Rigamonti N, Grioni M, et al. Modulators of arginine metabofism support cancer immunosurveillance[J]. BMC Immunol, 2009, 10: 1. 被引量:1

共引文献15

同被引文献47

  • 1黄云胜,施志明.肺积方对肺癌免疫逃逸干预作用的临床研究[J].中国中西医结合杂志,2007,27(6):501-504. 被引量:32
  • 2魏泓.医学实验动物学[M]第2版[M].成都:四川科学技术出版社,2001.499-500. 被引量:2
  • 3陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1997.244、273、279. 被引量:10
  • 4Ray A. Adipokine leptin in obesity-related pathology of breast cancer[J]. J Biosci ,2012,37(2) :289-294. 被引量:1
  • 5Wolin KY, Carson K, Colditz GA. Obesity and cancer[ J ]. Oncol- ogist,2010,15 (6) :556-565. 被引量:1
  • 6Jarde T, Perrier S, Vasson MP, et al. Molecular mechanisms of leptin and adiponectin in breast cancer[ J ]. Eur J Cancer, 2011, 47(1) :33-43. 被引量:1
  • 7Binai NA,Damert A,Carra G,et al. Expreesion of estrogen recep- tor alpha increases leptin-induced STAT3 activity in breast cancer [J]. Int J Cancer,2010,127( 1 ) :55-66. 被引量:1
  • 8Saxena NK, Vertinno PM, Anania FA, et al. Leptin-induved growth stimulation of breast cancer ceils involves recruitment of histone acetyltransferases and mediator complex to CYCLINDI promoter via activation of STAT3[J]. Biol Chem,2007,282(18) :13316-13325. 被引量:1
  • 9Jarde T,Gladefie-Chezet F,Gonealves-Mendes N,et al. Involve- ment of adiponectin and leptin in breast cancer:clinical and in vitro studies [ J ]. Endocr Relat Cancer,2009,16 (4) : 1197-1210. 被引量:1
  • 10Schepelman S, Ogilvie LM, Hedley D, et al. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic asenovirus expressing carboxypeptidase G2 [ J ]. Cancer Res, 2007,67 (10) :4949-4955. 被引量:1

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部